Use of Anticoagulants and Dosing Appropriateness of Apixaban for New-Onset Atrial Fibrillation Among Hemodialysis Patients

Volume: 79, Issue: 6, Pages: 909 - 912
Published: Jun 1, 2022
Abstract
Atrial fibrillation (AF) affects 21% of patients with kidney failure undergoing hemodialysis (HD).1Johansen K.L. Chertow G.M. Foley R.N. et al.US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States.Am J Kidney Dis. 2021; 77(4): A7-A8Abstract Full Text Full Text PDF Scopus (224) Google Scholar AF is associated with 2-fold higher adjusted risk of ischemic stroke and 9 times higher adjusted mortality risk...
Paper Details
Title
Use of Anticoagulants and Dosing Appropriateness of Apixaban for New-Onset Atrial Fibrillation Among Hemodialysis Patients
Published Date
Jun 1, 2022
Volume
79
Issue
6
Pages
909 - 912
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.